What is the recommended treatment for an otherwise uncomplicated dry (non‑productive) cough?

Treatment of Uncomplicated Dry Cough

For uncomplicated dry cough, start with honey and lemon as first-line therapy, which provides relief comparable to over-the-counter preparations at no cost and without adverse effects. 1

Initial Red-Flag Assessment

Before initiating symptomatic treatment, rule out serious pathology that requires immediate diagnostic workup rather than cough suppression:

• Hemoptysis mandates urgent imaging and bronchoscopy 1
• Prominent systemic illness (high fever, severe malaise) suggests bacterial pneumonia requiring targeted evaluation 1
• Unexplained weight loss or smoking history warrants urgent imaging and specialist referral for possible malignancy 1
• Suspected foreign body requires bronchoscopy 1

First-Line Non-Pharmacological Therapy

• Honey combined with lemon is the recommended initial treatment because patients report benefit equivalent to pharmacological preparations, with zero cost and no adverse effects 2, 1
• Most over-the-counter cough products lack specific pharmacologic benefit for acute dry cough, supporting honey-lemon as the preferred first approach 1
• Environmental modification including elimination of dust, dander, and other triggers is reasonable given the underlying pathophysiology 2
• Humidified air (vaporizers) may provide relief, particularly in low-humidity environments 2

Pharmacological Options When Non-Pharmacological Measures Fail

Dextromethorphan (Preferred Antitussive)

• Dose 30–60 mg for short-term use (≤7 days) provides effective cough suppression; this exceeds the subtherapeutic standard over-the-counter dose of 15–30 mg 1, 3
• Maximum cough-reflex suppression occurs at 60 mg, with a dose-response relationship demonstrated in controlled trials 2, 1
• Daily dosing should not exceed 120 mg 1
• This non-sedating opiate has demonstrated efficacy in meta-analyses for acute cough 2, 1
• Critical pitfall: When prescribing higher doses, verify that combination products do not contain acetaminophen or other agents that can accumulate to toxic levels 1

Menthol Inhalation (Adjunctive)

• Inhaled menthol provides acute, short-duration cough-reflex suppression useful for immediate symptom relief 2, 1
• Can be administered as menthol crystals (BPC) or proprietary capsules 2, 1
• Effect is brief and requires repeated dosing 2

First-Generation Antihistamines (Nocturnal Cough Only)

• Sedating antihistamines (diphenhydramine, chlorpheniramine) may reduce nocturnal cough but cause drowsiness 2, 1
• Avoid in older adults due to anticholinergic risks including cognitive impairment, urinary retention, and falls 1

Therapies NOT Recommended

• Codeine and pholcodine provide no greater efficacy than dextromethorphan but have significantly higher adverse-effect profiles (drowsiness, nausea, constipation, dependence risk) and are therefore not recommended 2, 1, 3
• Antibiotics have no role in uncomplicated acute viral cough and contribute to antimicrobial resistance 2, 1, 3
• N-acetylcysteine has not demonstrated consistent benefit for acute dry cough and should not be used for this indication 1, 4

Duration and Follow-Up Strategy

• Expected duration: Acute viral cough typically lasts 10–14 days after the initial visit, with most resolving within 3 weeks 2, 1
• Reassessment threshold: If cough persists beyond 3 weeks, discontinue antitussive therapy and initiate diagnostic workup for chronic cough rather than continuing symptomatic treatment 1, 3
• Refer to the illness as a "chest cold" rather than "bronchitis" when counseling patients, as the term "bronchitis" increases patient expectation for antibiotics 2

Diagnostic Workup for Persistent Cough (>3 Weeks)

When cough persists beyond 3 weeks, systematic evaluation is required:

• Chest radiography and spirometry to identify underlying chronic lung disease 3, 5
• Asthma (cough-variant): Trial of oral corticosteroids for 2 weeks 1, 5
• ACE-inhibitor–induced cough: Discontinue the ACE inhibitor 1
• Gastroesophageal reflux disease: Intensive proton-pump inhibitor therapy for at least 3 months, even without gastrointestinal symptoms 1, 5
• Upper airway disease/rhinosinusitis: One-month trial of topical nasal corticosteroids 1, 5
• Smoking: Cessation leads to significant improvement or resolution 1

Key Clinical Pitfalls to Avoid

• Do not prescribe subtherapeutic dextromethorphan doses (15–30 mg) for severe dry cough; use 30–60 mg 1, 3
• Do not use codeine-containing products; they offer no advantage over dextromethorphan and increase harm 2, 1, 3
• Do not prescribe antibiotics for acute viral cough; most cases are self-limiting and antibiotics contribute to resistance 2, 1, 3
• Do not continue antitussive therapy if cough persists beyond 3 weeks; pursue diagnostic workup instead 1, 3
• Do not suppress productive coughs; clearance of secretions is physiologically beneficial 1